Home › News › Pharma Industry News › Archive

Pharmaceutical Industry News Archive

Get news By email or subscribe to our News feeds.

All News Consumer Pharma New Drugs Pipeline Clinical Trials

December 2007

December 3

FDA Advisors Declare 'FDA Science and Mission at Risk' Bruker BioSciences Corporation Announces Agreement to Acquire the Bruker BioSpin Group for $914 Million in Cash and Stock Evotec Completes Divesture of Chemical Development Business to Aptuit Santarus Licenses Rights to GlaxoSmithKline for Zegerid Immediate-Release Omeprazole Products in over 100 Countries StemCells, Inc. Exploring Acquisition of Progenitor Cell Therapy, LLC Addex and Merck & Co., Inc. Collaborate to Develop Drugs for Parkinson's Disease Do Medical Schools Affect the Way Future Doctors Interact with Drug Companies? Sanofi-Aventis Inaugurates First Asian Development Centre for Pharmaceuticals in Goa, India Novartis Further Strengthens Biologics Capabilities in Expansion of MorphoSys Collaboration MorphoSys and Novartis Forge New Strategic Alliance to Establish Innovative Therapeutic Antibody Pipeline King Pharmaceuticals Reports Petition for Rehearing and Rehearing En Banc Denied

December 4

Merck Anticipates Earnings per Share Growth in 2008; Reaffirms Long-Term, Double-Digit Compound Annual EPS Growth from 2005 to 2010, Excluding Certain Items Watson and Biovail Settle Lawsuit Over Cardizem LA Decision Resources Inc. to Acquire Wood Mackenzie's Life Sciences Business Edgeline Holdings Announces the Acquisition of Intertech Bio Has Been Completed HBIO Divests the Majority of its Capital Equipment Business Mylan Announces Tentative FDA Approval Under PEPFAR for Tenofovir Disoproxil Fumarate Tablets AVEO Pharmaceuticals and Lilly Sign Collaboration for Clinical Drug Response Project Rep. Waxman Urges Strong Response to Report on FDA Resource Shortfalls Anika Therapeutics and Galderma Complete Termination of License, Development and Supply Agreements Compendia Bioscience Signs Oncomine Licensing Agreement with AstraZeneca Maxygen Licenses Dengue Vaccine Technology to sanofi pasteur Eisai and BioArctic Neuroscience Enter Exclusive Licensing Agreement with Novel Antibody Treatment for Alzheimer's Disease FDA MedWatch - Desmopressin Acetate - Product Labeling Updated To Include Important New Information About Severe Hyponatremia And Seizures Nabi Biopharmaceuticals Completes Sale of Nabi Biologics to Biotest AG Bruker BioSciences Corporation Announces Agreement to Acquire the Bruker BioSpin Group for $914 Million in Cash and Stock

December 5

Amarin Signs Agreement to Acquire Ester Neurosciences Pfizer and Adolor Enter into Exclusive Worldwide Collaboration to Develop and Commercialize Novel Pain Compounds Synta Receives $80 Million Upfront Payment from GlaxoSmithKline Revolution Health Acquires HealthTalk Akorn, Inc. Announces First ANDA Submission For Serum Institute of India, Ltd. Chemokine Therapeutics Withdraws Registration Statement and Implements a Cost Reduction Plan Bristol-Myers Squibb Announces Closing Of Its Colón, Panama Manufacturing Facility R&D Tax Credit Essential for a Healthier America Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community Kentucky Pharmacists Event Urging Senate Minority Leader McConnell to Fix Flawed Medicaid Drug Reimbursement Rule

December 6

Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy IMPAX Submits Additional Information to FDA Related to ANDA For Generic Version of Opana ER BioCryst Provides Forodesine HCl Update Michigan Health Plans Continue Focus on Generics for Cost Savings Raven biotechnologies, inc. and Wyeth Pharmaceuticals Extend Evaluation Period of Selected Raven Antibodies Sun Pharma Announces Settlement of Litigation Over Generic Exelon Video and Photo: EMD Serono Launches easypod, New Electronic Growth Hormone Injection Device Sepragen Announces the Completion of Cyto Biologic Technologies Acquisition ATEL Ventures Portfolio Company, ARYx Therapeutics, Inc. Completes Initial Public Offering Safety Concerns Prompt Prime to Remove Avandia from Formulary Introducing the Brand New Report on Business Strategies for Different Types of Biogenerics QPS Announces Signing Agreement to Acquire Bio-Kinetic Clinical Applications, Gaining Phase I and Early Clinical Services NCPA Testifies Before House Small Business Committee

December 10

GlaxoSmithKline and OncoMed Pharmaceuticals Form Strategic Alliance to Develop Cancer Stem Cell Antibody Therapeutics Acquisition of Adams Respiratory Therapeutics by Reckitt Benckiser Meda: Competition Authority Approves Meda's Acquisition of Recip Eisai to Acquire MGI Pharmafor $41 Per Share in an All Cash Transaction Thalidomide Added to Standard Therapy Prolongs Overall Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75 New Data Show Glivec Halts Progression to Advanced Stages of Life-threatening Form of Leukemia in Sixth Year of Treatment Pivotal Phase 3 Romiplostim Study in Splenectomized Patients Meets Primary Endpoints Acura Pharmaceuticals, Inc. Announces Receipt of $30 Million Cash Payment and Closing of Agreement With King Pharmaceuticals Pivotal Phase III Data Showed Rivaroxaban Was Statistically Superior to Enoxaparin in Preventing Venous Thromboembolism (VTE) in Patients Following Hip Replacement Surgery ImmunoVaccine Technologies Inc. to Acquire Immunotope Inc. New Report Offers Hope for Closing Health Gap for African Americans, With Nearly 700 Medicines in Pipeline FDA's Safety Reviews of Prilosec and Nexium Find No Evidence of Increased Rates of Cardiac Events Commonwealth Biotechnologies Completes Integration Program for its Complementary Drug Discovery Businesses

December 12

AstraZeneca Files Patent Infringement Actions in Response to Crestor ANDAs AstraZeneca Files Patent Infringement Actions in Response to Crestor ANDAs West Pharmaceutical Services Announces Restructuring Plan for Tech Group Survey Finds At-Risk Consumers Interested in OTC Statin Use of Diabetes Medication by Older Adults Associated with Increased Risk of Serious Heart Problems, Death Influenza Pandemic Could Cost Canadian Economy $9 Billion Three Lots of Measles, Mumps and Rubella Vaccine Suspended from Use Generic Prescription Drugs Show Increasingly Greater Use in Southeastern Pennsylvania Medicis and Revance Announce Strategic Collaboration FDA Issues an FDA Alert and Information for Healthcare Professionals Sheet for Carbamazepine MPM BioEquities Demands VaxGen Drop Merger Plan with Raven Celsion Purchases 659,738 Shares of Celsion Common Stock from Boston Scientific

December 13

Biogen Idec Completes Review of Strategic Alternatives Court Grants Depomed's Motion for Summary Judgment of Patent Infringement Against IVAX Shire plc: Board Changes Merck Announces Voluntary Recall of Certain Lots of Pedvaxhib and Comvax Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation Elan Update European Pharmaceutical Industry is Key to Helping Eu Become the Most Competitive and Dynamic Knowledge-based Society in the World Odyssey Thera Receives Milestone Payments in Pfizer Collaboration Cholesterol-Lowering Drugs and the Risk of Hemorrhagic Stroke Novartis Launches Strategic Initiative to Improve Competitiveness in a Dynamically Changing Healthcare Environment The Labeling for Exjade (deferasirox) has Been Changed to Include Information about Postmarketing Reports of Hepatic Failure, Some with a Fatal Outcome

December 14

Neurocrine Announces Work Force Restructuring FDA Advisory Panel Recommends Against Approval of Merck's NDA for Non-prescription Mevacor (lovastatin) 20 mg GlaxoSmithKline, Via Its Center of Excellence for External Drug Discovery, Exercises Its Option to Further Develop and Commercialize Exelixis' Anti-Cancer C-MET Inhibitor XL880 European Medicines Agency Concludes New Advice to Doctors and Patients for Champix Needed European Medicines Agency Recommends Withdrawal of the Marketing Authorisations for Lumiracoxib-Containing Medicines Committee for Medicinal Products for Human Use Post-authorisation Summary of Positive Opinion for Humira Merck Settles Clean Water Act Violations at its Montgomery County, Pennsylvania Pharmaceutical Plant I-Flow Announces Agreement to Acquire AcryMed, Inc. Boston Scientific Agrees To Sell Fluid Management and Venous Access Businesses to Avista Capital Partners for $425 Million FDA Sends Wyeth Warning Letter Over Effexor Ad

December 17

Oxford Genome Sciences and Amgen to Jointly Discover Novel Therapeutic Antibodies in Cancer Highly Promising Dutch Research Into Alzheimer's Disease and Parkinson's Disease Gene Logic Inc. Completes Sale of Genomics Assets to Ocimum Biosolutions HBIO Board Unanimously Rejects Skystone's Offer to Acquire the Company. Defense Threat Reduction Agency Halts Contract Negotiations With Peregrine Pharmaceuticals as It Suffers $100 Million Cut in FY 2008 Budget for Its Transformational Medical Technologies Initiative (TMTI) Program OncoVista Increases Its Share in AdnaGen AG Ambrx Announces Drug Discovery Alliance With Eli Lilly and Company Oncothyreon to Receive $5 Million Payment Avista Capital Partners Agrees to Acquire Bristol-Myers Squibb Medical Imaging for Approximately $525 Million FDA Announces Updated Information Regarding Antiretroviral Agents Used as HIV Postexposure Prophylaxis for Occupational HIV Exposures Aspreva Obtains Shareholder Approval for Acquisition by Galenica

December 18

Lilly and BioMS Medical Announce Global Licensing and Development Agreement Galapagos Announces Milestone Payment of €7.5 Million in Osteoarthritis Alliance with Glaxosmithkline Astellas Pharma Inc. and Toray Industries, Inc. Launch PAH Agent in Japan Eisai Enters Into In-licensing Agreement with Minophagen Pharmaceutical for Liver Disease/Allergic Disease AgentsStronger Neo-Minophagen C and Glycyron Tablets Lu AA21004 For the Treatment of Mood and Anxiety Disorders Enters Into Clinical Phase III Sidney Taurel to Retire as Lilly CEO; John Lechleiter Named as Successor PM Announces Canada’s New Food and Consumer Safety Action Plan Pfizer to Acquire CovX to Extend Biotherapeutics Investment BioMarin Re-Acquires Rights to Kuvan in Canada From Merck Serono ActivBiotics Sells Proprietary Assets, Including Drug Product Candidates

December 19

FDA Grants Tentative Approval to First Generic for Antiretroviral Viread Idera Pharmaceuticals and Merck KGaA to Collaborate on Development of TLR9 Agonists for Treatment of Cancer Pharmos Corporation Announces President & COO Alan L. Rubino to Leave Company Decision Resources, Inc. Acquires Arlington Medical Resources, Inc. GlaxoSmithKline Completes Acquisition of Reliant Pharmaceuticals Alkermes Announces Receipt of $166 Million from Sale of Stake in Reliant Pharmaceuticals Antisense Pharma With New Management Structure Galapagos Announces Osteoporosis Collaboration with Lilly Biogen Idec Announces First Startup in Its Innovation Incubator AstraZeneca and Banner Alzheimer's Institute Collaborate to Evaluate New Tool Targeting Alzheimer's Disease DSM Dyneema to Become Separately Reporting Business Group Enzo Biochem Unit Signs Letter of Intent to Acquire Belgian Life Sciences Distributor

December 20

Akela Pharma Provides Corporate Update Exelixis Submits XL139 Diligence Report to Bristol-Myers Squibb Merck Serono and Flamel to Collaborate on an Extended Release Formulation for Therapeutic Proteins Lonza Withdraws Majority of Claims in Patent Lawsuit Against Northwest Biotherapeutics Compugen and Roche Sign Agreement to Identify Genetic Variations Predictive of Drug Response in Rheumatoid Arthritis Patients Hemispherx Biopharma Comments on 2005 BDO Audit News Valeant Pharmaceuticals Sells Hep-C Drug Infergen to Three Rivers Pharmaceuticals, LLC for $91 Million Altus Pharmaceuticals Reacquires ALTU-238 Global Development and Commercialzation Rights Marketing of Viadur (leuprolide acetate implant) to Phase Out by April 2008 Thermo Fisher Scientific Acquires Leading Chromatography Consumables Provider, La-Pha-Pack NCCN Updates Cancer- and Treatment-Related Anemia Guidelines Scripps Research Discovery Leads to Broad Potential Applications in CovX-Pfizer Deal Regeneron Closes $312 Million Common Stock Sale in Connection with Sanofi-Aventis Collaboration Agilent Technologies Completes Acquisition of Velocity11, a Leader in Life Science Lab Automation and Robotics

December 27

U.S. District Court Decision About Eisai's Legal Action Over Aricept ODT ANDA Filing MultiCell Technologies To Increase Focus on Therapeutic Candidates Notice of Conversion Right for Senior Subordinated Convertible Notes Due 2024 Astellas Won the Patent Infringement Suit on Oral Cephalosporin Antibiotic Cefzon Capsule Three Steps to Boost Asymchem's Investment in China MedCap Opposes VaxGen's Proposed Merger with Raven biotechnologies The Medical House PLC Announces Disposal of Loss-Making Sub-contract Machining Division Cell Therapeutics, Inc. Completes Acquisition of Lymphoma Drug Zevalin From Biogen Idec for Sales and Marketing in the United States Exelgen Announces Partnerships with Two Leading European Biotechnology Companies Columbia River Resources Inc. Acquires Cutting-Edge Pharmaceutical RFID Company

Pharmaceutical Industry News Archive

More News Resources

Printable Version Email Recommend Tweet Save or Share
(web2)